PULLACH, Germany, February 12, 2019 -- In a forward-looking move, the Johannes Burges Group (JBU) has set the course for the future of its operations, heralding a new chapter in its 110-year corporate history. Johannes Burges, sole proprietor and director of the Johannes Burges Group, has transferred his company shares to the Johannes Burges Family Foundation, which he founded as a succession regulation.
The Johannes Burges Group currently employs more than 900 people in Germany and Austria and achieved revenues of nearly Euro 250 million last year. The group consists of HERMES PHARMA Ges.m.b.H., HERMES ARZNEIMITTEL GmbH, and Bad Heilbrunner GmbH & Co KG.
By transferring the group shares, Johannes Burges has ensured the future independence and sustainability of the entire group of companies. All affiliated companies can continue to be managed in his spirit, while preserving a joint corporate culture, sustainable development – and independence from potential external investors. As a result, all customers – be they consumers, patients, pharmacists or B2B customers of HERMES PHARMA – can expect the same high level of quality of products and services in the future.
From now on, the Family Foundation is the owner of the Johannes Burges Group. Its board of directors will initially consist of the two HERMES managing directors, Holger Dietel and Jörg Wieczorek for a period of ten years. Johannes Burges is Chairman of the Board of Trustees; other members are HERMES PHARMA's Managing Director Dr. Andreas Schrepfer and attorney Dr. Wolfram Theiss, of the law firm Noerr LLP.
"By establishing the Family Foundation, we created a solid base for the future of the Group," said Johannes Burges. "The Foundation, initially conceived for a 30 year lifecycle, guarantees economic independence. We are able to continue our successful history and offer our employees security and a long-term perspective."
In addition, Johannes Burges is committed to his social responsibility. For this purpose, one of the beneficiaries of the Family Foundation is the non-profit HERMES-Johannes-Burges Foundation, which is dedicated to the promotion of preventive medicine and healthcare as well as related research.
About HERMES PHARMA
Johannes Burges Group of Companies
The Johannes Burges Group, headquartered in Pullach near Munich, employs more than 900 people in Germany and Austria and achieved revenues of nearly 250 million Euros last year. The group consists of HERMES ARZNEIMITTEL GmbH (Pullach), HERMES PHARMA Ges.m.b.H. (Vienna, Austria) and Bad Heilbrunner Naturheilmittel GmbH & Co KG (Bad Heilbrunn).
About HERMES PHARMA
HERMES PHARMA is the expert in the development and production of user-friendly oral dosage forms, including effervescent and chewable tablets, lozenges, orally disintegrating granules and instant drinks. The company provides custom solutions along the entire pharmaceutical value chain – from the development of new product ideas and formulations to production and regulatory support. For more than 40 years, leading pharmaceutical and healthcare companies around the globe work with HERMES PHARMA to expand their product lines and grow their brands. Further information is available at www.hermes-pharma.com.
Lucy Turpin Communications
+49 89 417761-14
Manager Marketing & PR
HERMES ARZNEIMITTEL GMBH -
Division HERMES PHARMA